Matthew T. Plavan, Chief Executive Officer at Arcadia Biosciences, Inc. (RKDA), bought 2,000 shares at $5.25 ($11K) on 2019-09-23, disclosed to the SEC on 2019-09-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ORGN | SELL | 2025-11-04 | $83K | — | Filing → |
| ORGN | SELL | 2025-03-07 | $8K | — | Filing → |
| ORGN | SELL | 2024-12-31 | $25K | — | Filing → |